News | ACC | July 15, 2022

ACC Names Dr. Melvin Echols as Chief Diversity, Equity and Inclusion Officer

The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer

Melvin R. Echols, MD, FACC 


July 15, 2022 — The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer, effective July 18. Echols will lead the College’s diversity, equity and inclusion strategy and programs, while also maintaining a portion of his current clinical and research responsibilities at Morehouse School of Medicine in Atlanta. 

"Fostering a diverse and inclusive cardiovascular workforce, while also advancing solutions to improve health equity among individual patients and populations, is fundamental to achieving ACC’s Mission of transforming cardiovascular care and improving heart health for all,” said ACC CEO Cathleen C. Gates. “As both a cardiologist and a cardiovascular disparities researcher, Dr. Echols brings a deep understanding of the profession, as well as demonstrated success in effectively advancing diversity, equity and inclusion initiatives and driving cultural change – competencies that will undoubtedly ensure we are able to deliver on our strategic diversity, equity and inclusion goals now and into the future.” 

Echols is currently an associate professor of cardiovascular disease at Morehouse School of Medicine and serves as program director for the Cardiovascular Disease Fellowship. He is also a practicing cardiologist specializing in heart failure and brings more than a decade of experience as a clinical trial investigator focusing on heart failure, quality improvement, social determinants of health, and health care disparities. In his role as Chief Diversity, Equity and Inclusion Officer, Echols will use his expertise and experiences to work with ACC members, staff, external partners and other stakeholders to identify and implement programmatic goals and develop actionable and sustainable solutions to achieving a more diverse, equitable and inclusive College and cardiovascular profession. Specifically, he will lead and facilitate ACC efforts to mitigate barriers to entry into the field of cardiology; build and expand educational initiatives like the new Internal Medicine Program; and lead and coordinate the diversity and inclusion efforts and training of both staff and members across the College. 

“In a time where polarization continues to permeate our society, we need the implicit core values of diversity, equity, and inclusion now more than ever,” Echols said. “I expect this role will permit me to listen actively, learn vigorously, and allow the needs of our society to lead the ACC towards impactful change.” 

Echols graduated from Morehouse School of Medicine in 2002 and completed Internal Medicine at Duke University in 2005. He completed his cardiovascular fellowship training at Duke University Medical Center. He is a member of the ACC, Association of Black Cardiologists, the Heart Failure Society of America, the American Society of Preventive Cardiology, and the American Heart Association

“The discovery of commonalities between people and culture while providing quality cardiovascular care to all is strengthened by diversity, and will ultimately improve health equity in our society,” Echols said. “Everyone has a part to play in this mission and should feel included in helping to make our society and the world better than yesterday.” 

For more information: www.acc.org 

Find more ACC22 conference coverage 


Related Content

News | Heart Failure

December 7, 2022 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home December 07, 2022
Home
News | Heart Failure

December 2, 2022 — Westchester resident, 62-year-old Miriam Nieves, is especially grateful this Thanksgiving season ...

Home December 02, 2022
Home
News | Heart Failure

December 2, 2022 — The U.S. Senate today passed the bipartisan Cardiovascular Advances in Research and Opportunities ...

Home December 02, 2022
Home
News | Heart Failure

December 1, 2022 — Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a new ...

Home December 01, 2022
Home
News | Heart Failure

November 22, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with ...

Home November 22, 2022
Home
News | Heart Failure

November 21, 2022 — Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide ...

Home November 21, 2022
Home
News | Heart Failure

November 22, 2022 — Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint ...

Home November 21, 2022
Home
News | Heart Failure

November 15, 2022 — Ten months after transplanting the first genetically-modified pig heart into a human patient ...

Home November 15, 2022
Home
News | Heart Failure

November 14, 2022 — When it comes to heart failure (HF), sex differencesare known to impact everything from risk factors ...

Home November 14, 2022
Home
News | Heart Failure

November 9, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase 3 ...

Home November 09, 2022
Home
Subscribe Now